Pharmafile Logo
Pharmafocus logo
Advanced Search
obese-3011213_960_720

Fat-fighting pharma business files for bankruptcy

March 15, 2018
Sales and Marketing Contrave, biotech, drugs, orexigen, pharma, pharmaceutical

Orexigen Therapeutics, a biotech that was one of a wave of companies bringing through weight-loss pills, has announced that it …

News

Andrew Witty takes on a new CEO position

March 15, 2018
Medical Communications Andrew Witty, GSK, Optum, UnitedHealth, biotech, drugs, pharma, pharmaceutical

Andrew Witty, who made his name working his way up the ranks at GSK to become its CEO, has revealed …

News
veeva_event

Top 5 Reasons Why You Should Attend Veeva R&D Summit, Europe

March 15, 2018
Medical Communications biotech, drugs, pharma, pharmaceutical, veeva

Veeva R&D Summit, Europe is an annual gathering of pharma, biotech and medical devices professionals in clinical, regulatory, quality, and …

News
saroukos

Takeda’s CFO departs forcing company to act

March 14, 2018
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Takeda, biotech, drugs, pharma, pharmaceutical

Takeda has announced that its Chief Financial Officer, James Kehoe, has decided to move on from the company to take …

Appointment
teva_copy

Teva denies wrongdoing in Cephalon pay-to-delay deal hearing

March 14, 2018
Research and Development, Sales and Marketing Cephalon, Pay to delay, Provogil, Teva, pay-to-delay, pharma

Teva has denied allegations from the European Commission (EC) that it engaged in illegal anti-competitive pay-to-delay tactics to maintain its …

News
philip_hammond

Hammond suggests NHS may receive cash boost

March 14, 2018
Medical Communications, Research and Development Autumn Budget, NHS, UK, biotech, drugs, pharma, pharmaceutical

The pressures on the NHS over the winter months exposed serious cracks in the service, with issues regarding underfunding, struggles …

News
architect_of_the_capitol

US “right to try” experimental drug bill defeated in House vote

March 14, 2018
Research and Development, Sales and Marketing FDA, House of representatives, Right to try, US, pharma

The divisive and much-talked-about “right to try” legislation designed to provide access for terminally ill Americans to experimental and unproven …

News
pills-384846_960_720

World’s first synthetic, non-biologic vaccine developed

March 14, 2018
Research and Development Vaccine, biotech, drugs, influenza, pharma, pharmaceutical

One of the major challenges in delivering vaccinations to all parts of the globe is the need to keep the …

News
abbvieuse_054_low

AbbVie secures further strong results for potential blockbuster

March 13, 2018
Research and Development AbbVie, biotech, drugs, elagolix, pharma, pharmaceutical

AbbVie’s elagolix has been slated as a blockbuster-in-the-making by analysts predicting big things for the potential treatment for uterine fibroids …

News
biocon-k8tc--621x414livemint

FDA inspection reveals cGMP issues at Biocon’s major Malaysia facility

March 13, 2018
Manufacturing and Production Biocon, CGMP, FDA, pharma

Biocon’s insulin production facility in Johar, Malaysia – the largest integrated insulin manufacturing facility in Asia – has been slapped …

News
fda_building_web

Adaxis-AZ immunotherapy combo hit by clinical hold after death

March 13, 2018
Manufacturing and Production, Research and Development Adaxis, AstraZeneca, Imfinzi, biotech, drugs, immunotherapy, pharma, pharmaceutical

Adaxis and AstraZeneca announced that they had agreed a combination program for axalimogene filolisbac and Imfinzi, respectively, back in 2014 …

News
shutterstock_159488225

Anthera pulls the plug on Sollpura after Phase 3 failure, shares plummet 84%

March 13, 2018
Manufacturing and Production, Research and Development Anthera, Eli Lilly, Sollpura, pharma, trial failure

Anthera Pharmaceuticals has announced that it is to terminate development of its investigational pancreatic enzyme replacement therapy (PERT) Sollpura after …

News
novartis_side_building

Novartis reshuffle begins under new CEO

March 13, 2018
Manufacturing and Production, Medical Communications Novartis, biotech, digital, drugs, pharma, pharmaceutical

It’s a common strategy that newly appointed CEOs will try to change the direction of the company via rejigging leadership …

News
biology-think-networking-physiology-brain-anatomy-2676370

Pfizer begins sell-off, shedding CNS drug to Biogen for $590m

March 13, 2018
Manufacturing and Production, Sales and Marketing Biogen, CNS, Pfizer, biotech, drugs, pharma, pharmaceutical

Pfizer’s decision to back out of the neuroscience space was a strategic move that send shudders through the entire industry, …

News
shutterstock_79370437

Drug safety: EudraVigilance and an evolving system

March 12, 2018
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing drug safety, pharma, pharmacovigilance

The importance of drug safety is back in the news due to sodium valproate and Ben Hargreaves examines how the …

Feature
astrazeneca-sign

AstraZeneca’s Brilinta proves safety in heart attack patients at Phase 3

March 12, 2018
Research and Development, Sales and Marketing AstraZeneca, Brilinta, heart attack

AstraZeneca has revealed new Phase 3 data on its direct-acting P2Y12 receptor antagonist Brilinta (ticagrelor) at the American College of …

News
shutterstock_92671375

Impax agrees to $35 million settlement over anticompetitive practices with Valeant generic

March 12, 2018
Sales and Marketing Impax, Medicis, Solodyn, Valeant, generic, pharma

Impax Pharmaceuticals has acquiesced to paying a $35 million settlement in order to resolve part of an antitrust lawsuit it …

News
martin_shkreli_house_committee_on_oversight_and_government_reform_2016

Martin Shkreli sentenced to seven years in jail for securities fraud

March 12, 2018
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Martin Shkreli, pharma

Three years after he became “the most hated man in America” overnight for jacking up the price of life-saving HIV-related …

News
shutterstock_36423250

Sanofi and Regeneron reveal strong data and a price drop for Praluent

March 12, 2018
Research and Development, Sales and Marketing Regeneron, Sanofi, pharma, praluent

Sanofi and Regeneron have revealed strong new data for its PCSK9 inhibitor Praluent showing the first-ever reduction in deaths within …

News

Hikma’s Advair generic delayed in the US

March 12, 2018
Sales and Marketing Advair, FDA, GSK, GlaxoSmithKline, pharma

Hikma Pharmaceuticals has been knocked back with the news that the FDA has delayed approval of its generic lung treatment …

News
The Gateway to Local Adoption Series

Latest content

BMS’ Opdivo/Yervoy combination accepted by Scottish Medicines Consortium for colorectal cancer

February 5, 2026

AstronauTx appoints Adam Rosenberg as Chair of the Board

February 5, 2026

Astellas Pharma’s Vyloy accepted by Scottish Medicines Consortium for gastric cancer

February 4, 2026

Angelini Pharma appoints Sergio Marullo di Condojanni as CEO

February 4, 2026

QV Bioelectronics secures £4.5m in funding for brain cancer therapy development

February 3, 2026